Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Monday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of CALA stock opened at $0.03 on Monday. The firm’s 50-day moving average is $0.02 and its two-hundred day moving average is $0.03. Calithera Biosciences has a 12 month low of $0.01 and a 12 month high of $0.50.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- What is the Hang Seng index?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What is Insider Trading? What You Can Learn from Insider Trading
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
